Journal Title
EMERGING INFECTIOUS DISEASES

EMERG INFECT DIS

ISSN / eISSN
1080-6040 / 1080-6059
Aims and Scope
Emerging Infectious Diseases is an open-access, peer-reviewed journal published monthly by the Centers for Disease Control and Prevention (CDC). Note that beginning with Volume 26, the journal began publishing online-only. Publication in EID enables compliance with the NIH Public Access Policy.

Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes.

The conclusions, findings, and opinions expressed by authors contributing to Emerging Infectious Diseases do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services.
Subject Area

IMMUNOLOGY

INFECTIOUS DISEASES

CiteScore
17.30 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Epidemiology Q1 #10/148
Medicine - Infectious Diseases Q1 #26/344
Medicine - Microbiology (medical) Q1 #13/140
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
IMMUNOLOGY Q1
INFECTIOUS DISEASES Q1
H-index
202
Country/Area of Publication
UNITED STATES
Publisher
Centers for Disease Control and Prevention (CDC)
Publication Frequency
Monthly
Year Publication Started
1995
Annual Article Volume
326
Open Access
YES
Contact
CENTERS DISEASE CONTROL, 1600 CLIFTON RD, ATLANTA, USA, GA, 30333
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Generally, there is no need to conduct in-depth research. The requirement is primarily focused on novelty.
The previous submission took six months and was reviewed by three experts. It was ultimately rejected due to the last reviewer's negative feedback.
This submission, on the other hand, went faster. It took a little over two months for the first review, followed by two minor revisions. Less than a month later, it was accepted after the second review.
2021-04-01

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More